Skip to main content
. 2013 Jun 21;27(9):1090–1097. doi: 10.1038/eye.2013.139

Figure 1.

Figure 1

Subvisible particle size distribution for particles (a) 10–24 μm and (b) 25–50 μm, and (c) the percentage of total particles that are silicone in all samples from each supplier (S1–S5) and reference bevacizumab. S1–S5, samples from suppliers S1–S5. P-values are based on a Student's t-test and analysis of variance and compared measurements of a representative batch from a single supplier at day 1 and day 14.